Is Molecular Partners AG stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Molecular Partners AG pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Tuesday 15th of March 2022 were paid CHF0.285 per share. Over the last 1 times between 2022 and 2022, Molecular Partners AG has paid CHF0.285 with an average of CHF0.29 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Molecular Partners AG 10 years ago, but if you had invested on Thursday 28th of November 2019 when the price was CHF16.60, you would have made a loss of CHF-11.52 per share or -69.40%
No, the average daily trading liquidity for Molecular Partners AG is CHF6 578 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
Molecular Partners AG has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Molecular Partners AG to be medium [0.7 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.